The Time Course of CO2 Laser-evoked Responses and of Skin Nerve Fibre Markers After Topical Capsaicin in Human Volunteers
Overview
Psychiatry
Authors
Affiliations
Objective: To assess the temporal relationship between skin nerve denervation and regeneration (dermal and intra-epidermal fibres, IENF) and functional changes (CO(2) laser-evoked potentials, LEPs, and quantitative sensory tests, QST) after topical cutaneous application of capsaicin.
Methods: Capsaicin (0.075%) was applied to the lateral calf for three consecutive days. QST, LEPs and skin biopsies were performed at baseline and time intervals up to 54days post-capsaicin treatment. Biopsies were immunostained with antibodies for PGP9.5, TRPV1, and GAP-43 (marker of regenerating nerve fibres), and analyzed for IENFs and dermal innervation (for GAP-43).
Results: At 1day post-capsaicin, cutaneous thermal sensitivity was reduced, as were LEPs. PGP9.5, TRPV1, and GAP-43 immunoreactive-nerve fibres were almost completely absent. By Day 12, LEPs had fully recovered, but PGP9.5 and TRPV1 IENF continued to be significantly decreased 54days post-capsaicin. In contrast, dermal GAP-43 immunoreactivity closely matched recovery of LEPs.
Conclusions: A good correlation was observed between LEPs and GAP-43 staining, in contrast to PGP9.5 and TRPV1. Laser stimulation is a non-invasive and sensitive method for assessing the initial IENF loss, and regenerating nerve fibres.
Significance: Assessing skin biopsies by PGP9.5 immunostaining alone may miss significant diagnostic and prognostic information regarding regenerating nerve fibres, if other approaches are neglected, e.g. LEPs or GAP-43 immunostaining.
Antibody selection and automated quantification of TRPV1 immunofluorescence on human skin.
Jin Y, Brennecke J, Sodmann A, Blum R, Sommer C Sci Rep. 2024; 14(1):28496.
PMID: 39557902 PMC: 11574049. DOI: 10.1038/s41598-024-79271-9.
Liao Z, Umar M, Huang X, Qin L, Xiao G, Chen Y Cell Prolif. 2023; 57(3):e13569.
PMID: 37994506 PMC: 10905355. DOI: 10.1111/cpr.13569.
Low Trend for VZV-Associated Disease Patients to Visit Neurologists.
Xu G, Xu S, Gong W, Dong S, Yu H J Multidiscip Healthc. 2023; 16:1379-1392.
PMID: 37215749 PMC: 10199679. DOI: 10.2147/JMDH.S412398.
Niimi Y, Gomez-Tames J, Wasaka T, Hirata A Front Neurosci. 2023; 16:1045942.
PMID: 36711140 PMC: 9880216. DOI: 10.3389/fnins.2022.1045942.
Javed H, Johnson A, Challagandla A, Emerald B, Shehab S Cells. 2022; 11(24).
PMID: 36552812 PMC: 9776507. DOI: 10.3390/cells11244049.